38869-46-4

Basic information

• Product Name: 1-(4-Chlorophenyl)piperazine dihydrochloride
• Synonyms: N-(4-CHLOROPHENYL) PIPERAZINE DIHYDROCHLORIDE;LABOTEST-BB LT00233216;1-(4-CHLOROPHENYL)-PIPERAZINE 2HCL;1-(4-CHLOROPHENYL)PIPERAZINE DIHYDROCHLORIDE;1-(P-CHLOROPHENYL) PIPERAZINE DIHYDROCHLORIDE;1-(4-CHLOROLPHENYL)PIPERAZINE HYDROCHLORIDE;1-(4-Chlorophenyl)piperazine x 2 HCl;Piperazine, 1-(4-chlorophenyl)-, dihydrochloride
• CAS NO: 38869-46-4
• Molecular Formula: C₁₀H₁₃ClN₂*2ClH
• Molecular Weight: 269.6
• EINECS: 254-165-0
• Product Categories: Nitrogen cyclic compounds;Piperidines, Piperidones, Piperazines;PiperazineDerivative;Piperaizine;Building Blocks;Halogenated Heterocycles;Heterocyclic Building Blocks;Piperazines;PiperazinesHeterocyclic Building Blocks
• Mol File: 38869-46-4.mol
• Article Data: 1

Chemical Properties

• Melting Point: 275-278 °C (dec.)(lit.)
• Boiling Point: 322.19°C (rough estimate)
• Flash Point: 192.6ºC
• Appearance: beige to slightly brown crystalline powder
• Density: 1.1428 (rough estimate)
• Vapor Pressure: 0.000113mmHg at 25°C
• Refractive Index: 1.5749 (estimate)
• CAS DataBase Reference: 1-(4-Chlorophenyl)piperazine dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-Chlorophenyl)piperazine dihydrochloride(38869-46-4)
• EPA Substance Registry System: 1-(4-Chlorophenyl)piperazine dihydrochloride(38869-46-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39-24/25
• WGK Germany: 3
• Hazardous Substances Data: 38869-46-4(Hazardous Substances Data)

Usage

Chemical Properties

beige to slightly brown crystalline powder

InChI:InChI=1/C10H13ClN2/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13/h1-4,12H,5-8H2/p+1

Downstream Products

• 1610759-80-2 1-(4-chloro-phenyl)-4-[2-(5-fluoro-indan-2-yl)-ethyl]-piperazine 
• 1610700-12-3 2-{2-[4-(4-chlorophenyl)-piperazin-1-yl]-ethyl}indan-1-one 
• 1610700-33-8 2-{2-[4-(4-chloro-phenyl)-piperazin-1-yl]-ethyl}-5-fluoro-indan-1-one ethylene acetal 
• 1359849-97-0 1-(4-chlorophenyl)-4-(3-(4-fluorophenoxy)propyl)piperazine 
• 1359849-93-6 1-(4-chlorophenyl)-4-(3-((4-fluorophenyl)thio)propyl)piperazine 
• 549544-14-1 3-chloro-1-(4-(4-chlorophenyl)piperazin-1-yl)propan-1-one 
• 234782-49-1 {1S-[4-(4-chlorophenyl)piperazine-1-sulfonylmethyl]-2-methylpropyl}carbamic acid, tert-butyl ester 
• 1159928-48-9 (1-piperidin-4-yl)methyl 4-(4-chlorophenyl)piperazine-1-carboxylate 
• 1159928-92-3 2-(4-methylpiperazin-1-yl)ethyl 4-(4-chlorophenyl)piperazine-1-carboxylate 
• 1159929-49-3 C₁₅H₂₀BrClN₂O 
• 333400-91-2 7-chloro-6-nitro-4-(4-phenylpiperazinyl)quinazoline 
• 182180-64-9 6-bromo-2-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]imidazo[1,2-a]pyridine 
• 182181-12-0 2-[[4-(4-Chlorophenyl)-1-piperazinyl]methyl]-8-methylimidazo[1,2-a]pyridine 

Relevant articles and documents

Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient

The present invention is a piperazinylalkylbenzofuran derivative of the formula wherein R1 represents a C1-4 alkyl group, R2 stands for a hydrogen atom, X means an oxygen atom, Y is a hydroxyl group, Z represents a hydrogen atom, Ar′ represents a diphenylmethyl group, a pyridyl group, a partially saturated 5-membered heterocyclic group or a phenyl group, n has a value of 0 or 1, and pharmaceutically suitable acid addition salts thereof.